Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 1/20 | 0.40 |
| ▸ | NUDT1 | P36639 | 3/20 | 0.40 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.40 |
| ▸ | GPR3 | P46089 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.37 |
| ▸ | MAPT | P10636 | 6/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.37 |
| ▸ | HPGD | P15428 | 2/20 | 0.37 |
| ▸ | GAA | P10253 | 2/20 | 0.37 |
| ▸ | MEN1 | O00255 | 2/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.36 |
| ▸ | ATM | Q13315 | 2/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | ADK | P55263 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18859597 | 0.92 | MEN1 (0.47) | ELANENUDT1ADORA2AGPR3ALDH1A1 | |
| SCHEMBL18859627 | 0.88 | ELANE (0.36) | ELANENUDT1ADORA2AGPR3ALDH1A1 | |
| SCHEMBL22274507 | 0.87 | ELANE (0.37) | ELANENUDT1GPR3ALDH1A1MAPT | |
| SCHEMBL18859780 | 0.87 | MAPT (0.38) | ELANEADORA2AGPR3ALDH1A1MAPT | |
| SCHEMBL18859608 | 0.85 | ELANE (0.34) | ELANENUDT1ADORA2AGPR3ALDH1A1 | |
| SCHEMBL22274340 | 0.85 | MEN1 (0.41) | ELANENUDT1ADORA2AALDH1A1MAPT | |
| SCHEMBL18859678 | 0.85 | ELANE (0.36) | ELANEGPR3ALDH1A1MAPTHPGD | |
| SCHEMBL18859662 | 0.84 | ELANE (0.34) | ELANENUDT1ADORA2AGPR3MAPT | |
| SCHEMBL22274328 | 0.84 | MEN1 (0.40) | ELANENUDT1ADORA2AALDH1A1MAPT | |
| SCHEMBL18859625 | 0.84 | GPR3 (0.39) | ELANENUDT1GPR3ALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3162806-B1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME | LT MATERIALS CO LTD (KR) | 2023-08-23 | — | — | EP | disclosed |
| US-10644244-B2 | Heterocyclic compound and organic light emitting device using same | LT MATERIALS CO., LTD. (KR) | 2020-05-05 | — | — | US | disclosed |
| US-20170141325-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME | HEESUNG MATERIAL LTD. (KR) | 2017-05-18 | — | — | US | disclosed |
| US-20170141325-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME | HEESUNG MATERIAL LTD. (KR) | 2017-05-18 | — | — | US | disclosed |
| EP-3162806-A2 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME | Heesung Material Ltd. (KR) | 2017-05-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170141325-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME | CRY1, CRY2, CYBA | ELANE 4401/4885NUDT1 170/4885ADORA2A 2164/4885 |
| US-10644244-B2 | Heterocyclic compound and organic light emitting device using same | CRY1, CRY2, CYBA | ELANE 4401/4885NUDT1 170/4885ADORA2A 2164/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.